Cai, Yiqing
Chen, Xiaomin
Lu, Tiange
Yu, Zhuoya
Hu, Shunfeng
Liu, Jiarui
Zhou, Xiangxiang
Wang, Xin
Funding for this research was provided by:
National Natural Science Foundation of China (No.82170189, No.82070203)
China Postdoctoral Science Foundation (No. 2021T140422)
Translational Research Grant of NCRCH (No.2020ZKMB01, No.2021WWB02)
Natural Science Foundation of Shandong Province (ZR2021YQ51)
Taishan Scholars Program of Shandong Province
Shandong Provincial Engineering Research Center of Lymphoma
Key Technology Research and Development Program of Shandong (No.2018CXGC1213)
Academic Promotion Programme of Shandong First Medical University (No. 2019QL018)
Article History
Received: 19 April 2022
Accepted: 8 April 2023
First Online: 24 April 2023
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Medical Ethical Committee of Shandong Provincial Hospital. Informed consent was obtained from all patients and healthy donors in this study.
: Not Applicable.
: The authors declare no competing interests.